SCHEMBL4178311

SCHEMBL4178311

CCCc1n[nH]cc1-c1cc(O)c2ccc(OC)c(C)c2n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.35
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
ALOX5 P09917 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
HMGCR P04035 1/20 0.32
HTT P42858 2/20 0.32
ALDH1A1 P00352 2/20 0.32
RAD52 P43351 1/20 0.32
MAPT P10636 4/20 0.32
SMPD3 Q9NY59 1/20 0.31
KDM4E B2RXH2 3/20 0.31
HPGD P15428 2/20 0.31
GFER P55789 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
HSD17B10 Q99714 1/20 0.31
ADORA3 P0DMS8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4182845 0.91 MAPT (0.34) PDE10AMEN1KMT2APOLBGAA
SCHEMBL4191730 0.89 SLC10A2 (0.33) MEN1KMT2APOLBGAAHTT
SCHEMBL4189834 0.87 MAPK1 (0.37) MEN1KMT2AHTTALDH1A1RAD52
SCHEMBL4183205 0.86 KDM4E (0.33) PDE10AMEN1KMT2APOLBGAA
SCHEMBL4178062 0.84 PDE4A (0.34) POLBGAAHTTALDH1A1KDM4E
SCHEMBL4187144 0.83 ALDH1A1 (0.38) KMT2AALDH1A1RAD52MAPTKDM4E
SCHEMBL4185269 0.78 KDM4E (0.34) MEN1KMT2AHTTALDH1A1RAD52
SCHEMBL4177972 0.76 SLC10A2 (0.33) KMT2AGAAHTTRAD52KDM4E
SCHEMBL7917644 0.74 SREBF2 (0.41) MEN1KMT2APOLBGAAALDH1A1
SCHEMBL4177976 0.73 KMT2A (0.31) PDE10AKMT2AGAAHTTRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009014730-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2009-01-29 WO disclosed